Evidence map›Paper›PMID 22311974›Full record

ArticleThe Journal of biological chemistry2012

Reactive oxygen species and mitochondrial sensitivity to oxidative stress determine induction of cancer cell death by p21.

Ionica Masgras, Samantha Carrera, Petra J de Verdier, Paul Brennan, Aneela Majid, Wan Makhtar, Eugene Tulchinsky, George D D Jones, Igor B Roninson, Salvador Macip

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 96 citations in OpenAlex.

  1. Review
  2. Article
  3. Tumor-promoting UBR4 coordinates impaired mitophagy-associated senescence and lung adenocarcinoma pathogenesis.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
  5. Prdx6 regulatesAnimal cells and systems · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Ionica MasgrasDepartment of Biochemistry, University of Leicester, Leicester LE1 9HN, United Kingdom.
Samantha CarreraDepartment of Biochemistry, University of Leicester, Leicester LE1 9HN, United Kingdom.
Petra J de VerdierDepartment of Molecular Medicine and Surgery, Urology Laboratory, Karolinska Institutet, 171 76 Stockholm, Sweden.
Paul BrennanDepartment of Infection, Immunity, and Biochemistry, School of Medicine, Cardiff University, Cardiff CF14 4XN, United Kingdom, and.
Aneela MajidMedical Research Council (MRC) Toxicology Unit, University of Leicester, Leicester LE1 9HN, United Kingdom.
Wan MakhtarDepartment of Cancer Studies and Molecular Medicine, University of Leicester, Leicester LE1 9HN, United Kingdom.
Eugene TulchinskyDepartment of Cancer Studies and Molecular Medicine, University of Leicester, Leicester LE1 9HN, United Kingdom.
George D D JonesDepartment of Cancer Studies and Molecular Medicine, University of Leicester, Leicester LE1 9HN, United Kingdom.
Igor B RoninsonTranslational Cancer Therapeutics Program Department of Pharmaceutical and Biomedical Sciences, South Carolina College of Pharmacy, University of South Carolina, Columbia, South Carolina 29208.
Salvador MacipDepartment of Biochemistry, University of Leicester, Leicester LE1 9HN, United Kingdom. Electronic address: sm460@le.ac.uk.
University of Leicester · GBCardiff University · GBMedical Research Council · GBUniversity of South Carolina · US

Funding

Secretory Patterns of Senescent Tumor CellsR01AG028687 · NIA · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI RONINSON, IGOR B · 2007 to 2011
$1.6M
Medical Research CouncilNIA NIH HHS R01 AG028687
6 · The paper itself

Abstract

p21(Waf1/Cip1/Sdi1) is a cyclin-dependent kinase inhibitor that mediates cell cycle arrest. Prolonged p21 up-regulation induces a senescent phenotype in normal and cancer cells, accompanied by an increase in intracellular reactive oxygen species (ROS). However, it has been shown recently that p21 expression can also lead to cell death in certain models. The mechanisms involved in this process are not fully understood. Here, we describe an induction of apoptosis by p21 in sarcoma cell lines that is p53-independent and can be ameliorated with antioxidants. Similar levels of p21 and ROS caused senescence in the absence of significant death in other cancer cell lines, suggesting a cell-specific response. We also found that cells undergoing p21-dependent cell death had higher sensitivity to oxidants and a specific pattern of mitochondrial polarization changes. Consistent with this, apoptosis could be blocked with targeted expression of catalase in the mitochondria of these cells. We propose that the balance between cancer cell death and arrest after p21 up-regulation depends on the specific effects of p21-induced ROS on the mitochondria. This suggests that selective up-regulation of p21 in cancer cells could be a successful therapeutic intervention for sarcomas and tumors with lower resistance to mitochondrial oxidative damage, regardless of p53 status.

Indexed as

Gene Expression Regulation, NeoplasticOxidative StressCell Cycle CheckpointsCell DeathCell Line, TumorCellular SenescenceCyclin-Dependent Kinase Inhibitor p21HumansMitochondriaReactive Oxygen SpeciesSarcomaTumor Suppressor Protein p53Up-RegulationCDKN1A protein, humanCyclin-Dependent Kinase Inhibitor p21Reactive Oxygen SpeciesTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID22311974
PMCPMC3322987
OpenAlexW2069823876

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.